Quick Takeaways
- Stephane Bancel has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $511,509,633.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Stephane Bancel
- Location
- Cambridge, MA
- Summary
- The estimated net worth of Stephane Bancel is at least $511,509,633 dollars as of 03 Mar 2026. Stephane Bancel is the Chief Executive Officer, Director of Moderna, Inc. and owns shares of Moderna, Inc. (MRNA) stock worth about $511.51M.
- Signature
- /s/ James Dillon, as Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Stephane Bancel and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Moderna, Inc. ($511,509,633).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Stephane Bancel
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | Chief Executive Officer, Director | $511,509,633 | 01 Mar 2026 | ||
| GENB | Generate Biomedicines, Inc. | Director | 26 Feb 2026 |
Insider Transactions Reported by Stephane Bancel:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.